Lymph node spread in early esophageal cancer
Part of Cancer clinical trials.
This trial looks at how early-stage esophageal cancer spreads to lymph nodes. It uses CT scans and pathology reports to understand patterns, which may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with early-stage esophageal squamous cell carcinoma (T1 stage, meaning the cancer is only in the inner layer of the esophagus).
- You had a contrast-enhanced CT scan (a special type of CT that uses dye) within two weeks before your surgery.
- You have not received any chemotherapy, radiation, or endoscopic treatment for this cancer before your surgery.
- Your CT scan images are good quality and complete, and your pathology results are fully available.
- Your cancer has not spread to other parts of the body (no metastasis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether substances called metabolites in your blood and breast tissue can help predict if breast cancer has spread to the first lymph node (sentinel node). If you are scheduled for breast cancer surgery and have not had prior treatment, the study team will use your blood and tissue samples to try to improve prediction.
This study uses images of your removed lymph nodes to see if cancer has spread there. It may help doctors better understand your cancer without needing extra tests.
This study looks at how esophageal (or esophagus-stomach junction) cancer spreads to nearby lymph nodes. Results may help doctors understand where cancer cells are likely to be, potentially improving future surgery planning.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
This study looks at how often cancer has spread to lymph nodes in people with esophageal squamous cell carcinoma. It may help doctors plan better treatment. You may be eligible if your cancer hasn't spread to other organs and you haven't had another cancer.
This trial looks at how often a specific lymph node (106TBL) is involved in esophageal squamous cell carcinoma. It may help guide treatment decisions for people who have not had other cancers and whose tumor is in the chest (not the neck).
Hear when a new ESCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.